Science4Beauty, a Polish biotech company specializing in next-generation skincare products, has successfully closed a 7 million PLN (approximately 1.68 million USD) Series A investment round. The funding was led by venture capital firm 4growth VC and investment company Hard2beat, alongside backing from a consortium of experienced business angels.
The capital injection represents a significant milestone for the Warsaw-based startup, which has developed proprietary recombinant-protein technology designed to advance skincare formulations. This approach marks a departure from conventional skincare development, positioning Science4Beauty within the growing intersection of biotechnology and cosmetics innovation.
Building on Scientific Foundations
Science4Beauty’s focus on recombinant-protein technology reflects a broader trend within the European healthtech and biotech sectors, where companies increasingly leverage molecular biology to create more effective personal care solutions. The company’s platform enables the development of skincare products with enhanced efficacy compared to traditional formulations, addressing a market segment that continues to demand scientifically-backed beauty innovations.
The participation of both institutional investors and angel backers in this round suggests confidence from multiple segments of the investment community. 4growth VC, known for supporting technology-driven ventures across Central and Eastern Europe, and Hard2beat, which has built a track record in supporting innovative companies, bring complementary expertise and networks to support the startup’s growth trajectory.
Strategic Capital Deployment
While specific details regarding how Science4Beauty intends to deploy the freshly raised capital remain limited, typical uses for Series A funding in the biotech and healthtech space include accelerating product development, expanding manufacturing capabilities, scaling commercial operations, and strengthening regulatory compliance infrastructure. For a company focused on skincare innovation, these investments would be essential for moving from development phases toward market expansion.
The funding round underscores the continued dynamism within Poland’s startup ecosystem, particularly in science-driven sectors. Eastern European countries have increasingly established themselves as important hubs for biotech and healthtech innovation, attracting both international and regional investors seeking exposure to breakthrough technologies.
European Healthtech Momentum
Science4Beauty’s successful fundraising occurs within a broader context of sustained investor interest in European health and wellness technologies. The continent’s strong scientific infrastructure, combined with growing consumer demand for evidence-based skincare solutions, continues to attract capital to companies developing novel approaches to personal care and wellness. The involvement of regional investors like 4growth VC demonstrates how local venture ecosystems are maturing to support ambitious deep-tech ventures alongside more traditional software-focused startups.
As Science4Beauty moves forward with its expanded resources, the company will be positioned to advance its research initiatives and potentially bring its recombinant-protein formulations to market at a larger scale, contributing to the evolving landscape of scientifically-grounded beauty innovation in Europe.